drugset / Trial / NCT07157722
Evaluating the Effect of N-Acetyl Cysteine and Alpha Lipoic Acid in Patients With Beta Thalassemia
RandomizedParallel-groupDouble-blindTreatment
Summary
The current study is to investigate the potential roles of N-acetyl cysteine and Alpha-lipoic acid in patients with beta-thalassemia.
Timeline
- Start
- 2025-08-30
- Primary completion
- 2025-12-30
- Completion
- 2026-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | N-acetylcysteine | Small molecule | 600 mg | Oral |
| Comparator | alpha-lipoic acid | Small molecule | 600 mg | Oral |
| Comparator | Deferasirox | Unknown | — | — |